Teru Kanda
Overview
Explore the profile of Teru Kanda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sekine R, Takeda K, Suenaga T, Tsuno S, Kaiya T, Kiso M, et al.
Commun Biol
. 2025 Jan;
8(1):27.
PMID: 39815031
Future pandemic threats may be caused by novel coronaviruses and influenza A viruses. Here we show that when directly added to a cell culture, 12mer guanine RNA (G12) and its...
2.
Kitamura H, Kukimoto I, Yajima M, Ikuta K, Sasaki K, Kanda T
Virology
. 2024 Dec;
603:110359.
PMID: 39721196
More than 95% of adult humans worldwide are latently infected with Epstein-Barr virus (EBV). Recent studies indicated that different EBV strains colonize different regions of Asia, where nasopharyngeal carcinoma (NPC)...
3.
Ikuta K, Yajima M, Kitamura H, Aoki S, Kanda T
J Med Virol
. 2024 Dec;
96(12):e70138.
PMID: 39717911
Placental trophoblasts constitute the interface between the fetal and maternal environments and physically prevent maternal-fetal viral transmission. However, congenital human cytomegalovirus (HCMV) infection in the early stages of pregnancy results...
4.
Mori S, Kohyama M, Yasumizu Y, Tada A, Tanzawa K, Shishido T, et al.
Cell
. 2024 Sep;
187(21):6071-6087.e20.
PMID: 39276775
Major histocompatibility complex class II (MHC-II) is the most significant genetic risk factor for systemic lupus erythematosus (SLE), but the nature of the self-antigens that trigger autoimmunity remains unclear. Unusual...
5.
Sugimoto A, Watanabe T, Matsuoka K, Okuno Y, Yanagi Y, Narita Y, et al.
Microbiol Spectr
. 2023 Jul;
11(4):e0044023.
PMID: 37409959
The growth transformation of primary B cells by Epstein-Barr virus (EBV) is the initial step in the development of posttransplant lymphoproliferative disorder (PTLD). We performed electron microscopic analysis and immunostaining...
6.
Wongwiwat W, Fournier B, Bassano I, Bayoumy A, Elgueta Karstegl C, Styles C, et al.
J Virol
. 2022 May;
96(12):e0039422.
PMID: 35612313
The main target cells for Epstein-Barr virus (EBV) infection and persistence are B lymphocytes, although T and NK cells can also become infected. In this paper, we characterize the EBV...
7.
Lu X, Hosono Y, Nagae M, Ishizuka S, Ishikawa E, Motooka D, et al.
J Exp Med
. 2021 Oct;
218(12).
PMID: 34647971
Adaptive immunity is a fundamental component in controlling COVID-19. In this process, follicular helper T (Tfh) cells are a subset of CD4+ T cells that mediate the production of protective...
8.
Abe H, Kunita A, Otake Y, Kanda T, Kaneda A, Ushiku T, et al.
PLoS One
. 2021 Sep;
16(9):e0256440.
PMID: 34469459
Epstein-Barr virus (EBV)-associated gastric carcinoma (EBVaGC) is a distinct molecular subtype of gastric cancer characterized by viral infection and cellular abnormalities, including loss of AT-rich interaction domain 1A (ARID1A) expression...
9.
Yanagi Y, Okuno Y, Narita Y, Masud H, Watanabe T, Sato Y, et al.
Virology
. 2021 Feb;
557:44-54.
PMID: 33639481
Epstein-Barr virus (EBV) is a causative agent of infectious mononucleosis and several types of malignancy. RNAseq of peripheral blood primary B cell samples infected with wild-type EBV revealed that expression...
10.
Yajima M, Kakuta R, Saito Y, Kitaya S, Toyoda A, Ikuta K, et al.
J Gen Virol
. 2021 Jan;
102(3).
PMID: 33433312
Epstein-Barr virus (EBV) establishes lifelong latent infection in the majority of healthy individuals, while it is a causative agent for various diseases, including some malignancies. Recent high-throughput sequencing results indicate...